Consolidated Statement Of Income

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7557806

Concept 2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
Consolidated statement of income
Statement of income
Net sales
6,660,000,000 JPY
53,579,000,000 JPY
298,000,000 JPY
60,538,000,000 JPY
-77,000,000 JPY
60,461,000,000 JPY
50,791,000,000 JPY
259,000,000 JPY
-73,000,000 JPY
56,681,000,000 JPY
56,607,000,000 JPY
5,630,000,000 JPY
Operating revenue
1,732,000,000 JPY
1,371,000,000 JPY
Cost of sales
31,876,000,000 JPY
30,255,000,000 JPY
Operating expenses
Selling, general and administrative expenses
23,476,000,000 JPY
21,556,000,000 JPY
Operating expenses
Operating expenses
1,073,000,000 JPY
653,000,000 JPY
Operating profit (loss)
409,000,000 JPY
5,779,000,000 JPY
-6,000,000 JPY
658,000,000 JPY
6,181,000,000 JPY
-1,073,000,000 JPY
5,108,000,000 JPY
5,088,000,000 JPY
-16,000,000 JPY
-653,000,000 JPY
717,000,000 JPY
5,449,000,000 JPY
4,795,000,000 JPY
376,000,000 JPY
Ordinary profit (loss)
603,000,000 JPY
5,232,000,000 JPY
717,000,000 JPY
4,880,000,000 JPY
Net sales
Gross profit (loss)
28,584,000,000 JPY
26,351,000,000 JPY
Operating expenses
Research and development expenses
4,227,000,000 JPY
3,598,000,000 JPY
Extraordinary income
124,000,000 JPY
9,683,000,000 JPY
Other
JPY
258,000,000 JPY
Cost of sales
Non-operating income
3,000,000 JPY
433,000,000 JPY
0 JPY
379,000,000 JPY
Dividend income
338,000,000 JPY
258,000,000 JPY
Interest income
0 JPY
0 JPY
Selling, general and administrative expenses
Non-operating income
Other
2,000,000 JPY
94,000,000 JPY
0 JPY
120,000,000 JPY
Non-operating expenses
58,000,000 JPY
308,000,000 JPY
1,000,000 JPY
294,000,000 JPY
Interest expenses
3,000,000 JPY
50,000,000 JPY
0 JPY
56,000,000 JPY
Non-operating expenses
Other
3,000,000 JPY
57,000,000 JPY
0 JPY
27,000,000 JPY
Extraordinary losses
JPY
8,400,000,000 JPY
Impairment losses
JPY
5,941,000,000 JPY
11,000,000 JPY
5,953,000,000 JPY
5,953,000,000 JPY
JPY
JPY
Other
JPY
425,000,000 JPY
Profit (loss) before income taxes
603,000,000 JPY
5,357,000,000 JPY
717,000,000 JPY
6,163,000,000 JPY
Gross profit
Extraordinary income
Gain on sale of non-current assets
JPY
9,425,000,000 JPY
Gain on sale of investment securities
124,000,000 JPY
JPY
Income taxes - current
39,000,000 JPY
1,108,000,000 JPY
61,000,000 JPY
983,000,000 JPY
Extraordinary losses
Income taxes - deferred
-27,000,000 JPY
10,000,000 JPY
-27,000,000 JPY
890,000,000 JPY
Income taxes
11,000,000 JPY
1,118,000,000 JPY
34,000,000 JPY
1,873,000,000 JPY
Profit (loss)
591,000,000 JPY
591,000,000 JPY
591,000,000 JPY
591,000,000 JPY
4,238,000,000 JPY
682,000,000 JPY
682,000,000 JPY
682,000,000 JPY
4,290,000,000 JPY
682,000,000 JPY
Profit (loss) attributable to owners of parent
4,238,000,000 JPY
4,238,000,000 JPY
4,238,000,000 JPY
4,290,000,000 JPY
4,290,000,000 JPY
4,290,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
1,371,000,000 JPY
406,000,000 JPY
Remeasurements of defined benefit plans, net of tax
144,000,000 JPY
121,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
229,000,000 JPY
164,000,000 JPY
Other comprehensive income
1,745,000,000 JPY
692,000,000 JPY
Profit attributable to
Comprehensive income
5,983,000,000 JPY
4,982,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
5,983,000,000 JPY
4,982,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.